Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2023 Filed Jun 7, 2023 21:29 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
SaleCommon Stock | 1,371 | $37.87 | $51,912.92 |
DisclosureSEC source: 0001209191-23-035261 · doc4.xml · nonDerivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,626 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 01:34 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 1,357 | $37.87 | $51,382.81 |
DisclosureSEC source: 0001209191-23-035265 · doc4.xml · nonDerivative · entry 2 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,892 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 07, 2023 Filed Jun 7, 2023 21:33 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 5,326 | $37.87 | $201,668.99 |
DisclosureSEC source: 0001209191-23-035264 · doc4.xml · nonDerivative · entry 2 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,781 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 01:36 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 1,857 | $37.87 | $70,315.31 |
DisclosureSEC source: 0001209191-23-035266 · doc4.xml · nonDerivative · entry 2 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,356 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 01:31 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 616 | $37.87 | $23,324.84 |
DisclosureSEC source: 0001209191-23-035262 · doc4.xml · nonDerivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,053 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 01:28 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 1,099 | $37.87 | $41,613.64 |
DisclosureSEC source: 0001209191-23-035260 · doc4.xml · nonDerivative · entry 2 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,225 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 01:24 UTC |
McLoughlin DennisChief Customer Officer
|
SaleCommon Stock | 1,057 | $37.87 | $40,023.31 |
DisclosureSEC source: 0001209191-23-035258 · doc4.xml · nonDerivative · entry 2 McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,115 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 01:22 UTC |
GAUGLER DARYLChief Operating Officer
|
SaleCommon Stock | 1,047 | $37.87 | $39,644.66 |
DisclosureSEC source: 0001209191-23-035256 · doc4.xml · nonDerivative · entry 3 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,539 F2 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 01:20 UTC |
Ellis Ronald J. Jr.Chief Strategy Officer
|
SaleCommon Stock | 1,162 | $37.87 | $43,999.13 |
DisclosureSEC source: 0001209191-23-035255 · doc4.xml · nonDerivative · entry 2 Ellis Ronald J. Jr. · CIK 0001790670 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,909 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:32 UTC |
SLONIN JONATHANChief Clinical Officer
|
SaleCommon Stock | 471 | $38.99 | $18,364.76 |
DisclosureSEC source: 0001209191-23-035263 · doc4.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,813 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 205 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 21:29 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
SaleCommon Stock | 1,236 | $38.99 | $48,192.88 |
DisclosureSEC source: 0001209191-23-035261 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,997 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:34 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 1,301 | $38.99 | $50,727.29 |
DisclosureSEC source: 0001209191-23-035265 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,249 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 21:33 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 5,058 | $38.99 | $197,216.48 |
DisclosureSEC source: 0001209191-23-035264 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,107 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes an aggregate of 414 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:36 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 1,779 | $38.99 | $69,364.99 |
DisclosureSEC source: 0001209191-23-035266 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,213 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:31 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 591 | $38.99 | $23,043.68 |
DisclosureSEC source: 0001209191-23-035262 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,669 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:28 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 1,054 | $38.99 | $41,096.51 |
DisclosureSEC source: 0001209191-23-035260 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,324 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:26 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 4,521 | $38.55 | $174,284.55 |
DisclosureSEC source: 0001209191-23-035259 · doc4.xml · nonDerivative · entry 2 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,877 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:24 UTC |
McLoughlin DennisChief Customer Officer
|
SaleCommon Stock | 1,014 | $38.99 | $39,536.87 |
DisclosureSEC source: 0001209191-23-035258 · doc4.xml · nonDerivative · entry 1 McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,172 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes an aggregate of 416 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:22 UTC |
GAUGLER DARYLChief Operating Officer
|
SaleCommon Stock | 1,005 | $38.99 | $39,185.96 |
DisclosureSEC source: 0001209191-23-035256 · doc4.xml · nonDerivative · entry 2 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,586 F2 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 01:20 UTC |
Ellis Ronald J. Jr.Chief Strategy Officer
|
SaleCommon Stock | 1,114 | $38.99 | $43,435.97 |
DisclosureSEC source: 0001209191-23-035255 · doc4.xml · nonDerivative · entry 1 Ellis Ronald J. Jr. · CIK 0001790670 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,071 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 05, 2023 Filed Jun 8, 2023 01:23 UTC |
HASTINGS PAUL JDirector
|
SaleCommon Stock | 580 | $38.34 | $22,236.62 |
DisclosureSEC source: 0001209191-23-035257 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,599 Read SEC document |
| June 05, 2023 Filed Jun 8, 2023 01:18 UTC |
Brege LauraDirector
|
SaleCommon Stock | 600 | $38.74 | $23,244.00 |
DisclosureSEC source: 0001209191-23-035254 · doc4.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,547 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 05, 2023 Filed Jun 8, 2023 01:26 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 2,267 | $38.28 | $86,773.96 |
DisclosureSEC source: 0001209191-23-035259 · doc4.xml · nonDerivative · entry 1 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,398 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 215 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022. Read SEC document |
| June 05, 2023 Filed Jun 8, 2023 01:22 UTC |
GAUGLER DARYLChief Operating Officer
|
SaleCommon Stock | 1,000 | $38.74 | $38,740.00 |
DisclosureSEC source: 0001209191-23-035256 · doc4.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,591 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 22:28 UTC |
GAUGLER DARYLChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033985 · doc4.xml · derivative · entry 3 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2023-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The stock option vested in equal monthly installments over one year following the grant date, provided that the reporting person remained in continuous service with the issuer as of each vesting date. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 22:28 UTC |
GAUGLER DARYLChief Operating Officer
|
SaleCommon Stock | 2,500 | $39.08 | $97,700.00 |
DisclosureSEC source: 0001209191-23-033985 · doc4.xml · nonDerivative · entry 2 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,591 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · balance_after: Includes an aggregate of 197 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 22:28 UTC |
GAUGLER DARYLChief Operating Officer
|
Exercise / conversionCommon Stock | 2,500 | $34.00 | $85,000.00 |
DisclosureSEC source: 0001209191-23-033985 · doc4.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:07 UTC |
HASTINGS PAUL JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $29.90 | $0.00 |
DisclosureSEC source: 0001209191-23-030141 · doc4.xml · derivative · entry 3 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2023-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · derivative.exercise_date: The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 12, 2013. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:07 UTC |
HASTINGS PAUL JDirector
|
SaleCommon Stock | 7,000 | $41.85 | $292,950.00 |
DisclosureSEC source: 0001209191-23-030141 · doc4.xml · nonDerivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,179 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:07 UTC |
HASTINGS PAUL JDirector
|
Exercise / conversionCommon Stock | 7,000 | $29.90 | $209,300.00 |
DisclosureSEC source: 0001209191-23-030141 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| May 11, 2023 Filed May 15, 2023 22:53 UTC |
PACE GARY WDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $29.90 | $0.00 |
DisclosureSEC source: 0001209191-23-029616 · doc4.xml · derivative · entry 3 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2023-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 12, 2013. Read SEC document |
| May 11, 2023 Filed May 15, 2023 22:53 UTC |
PACE GARY WDirector
|
SaleCommon Stock | 5,015 | $41.78 | $209,526.70 |
DisclosureSEC source: 0001209191-23-029616 · doc4.xml · nonDerivative · entry 2 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,675 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.75 to $41.85, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 11, 2023 Filed May 15, 2023 22:53 UTC |
PACE GARY WDirector
|
Exercise / conversionCommon Stock | 7,000 | $29.90 | $209,300.00 |
DisclosureSEC source: 0001209191-23-029616 · doc4.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:34 UTC |
Brege LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $29.90 | $0.00 |
DisclosureSEC source: 0001209191-23-023336 · doc4.xml · derivative · entry 3 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2023-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · derivative.exercise_date: The option vested in 12 equal monthly installments, provided that the reporting person remained in continuous service with the issuer through each vesting date, and became fully exercisable on June 12, 2014. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:34 UTC |
Brege LauraDirector
|
SaleCommon Stock | 7,000 | $40.72 | $285,040.00 |
DisclosureSEC source: 0001209191-23-023336 · doc4.xml · nonDerivative · entry 2 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,147 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:34 UTC |
Brege LauraDirector
|
Exercise / conversionCommon Stock | 7,000 | $29.90 | $209,300.00 |
DisclosureSEC source: 0001209191-23-023336 · doc4.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 05, 2023 Filed Jan 7, 2023 00:04 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 546 | $38.31 | $20,917.26 |
DisclosureSEC source: 0001209191-23-002474 · doc4.xml · nonDerivative · entry 2 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,450 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 04, 2023 Filed Jan 7, 2023 00:04 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 158 | $39.09 | $6,176.69 |
DisclosureSEC source: 0001209191-23-002474 · doc4.xml · nonDerivative · entry 1 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,996 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 204 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:13 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 1,380 | $58.00 | $80,040.00 |
DisclosureSEC source: 0001209191-22-053275 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,378 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · balance_after: Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:04 UTC |
SLONIN JONATHANChief Clinical Officer
|
SaleCommon Stock | 308 | $55.70 | $17,155.60 |
DisclosureSEC source: 0001209191-22-044554 · doc4.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,079 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:06 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 476 | $55.70 | $26,513.20 |
DisclosureSEC source: 0001209191-22-044560 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,992 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 20:03 UTC |
HASTINGS PAUL JDirector
|
SaleCommon Stock | 533 | $56.95 | $30,354.35 |
DisclosureSEC source: 0001209191-22-042037 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,179 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 23:04 UTC |
SLONIN JONATHANChief Clinical Officer
|
SaleCommon Stock | 924 | $57.19 | $52,841.71 |
DisclosureSEC source: 0001209191-22-041521 · doc4.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,387 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 214 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:05 UTC |
LARANJEIRA CHARLES ANTHONYChief Technical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $38.35 | $0.00 |
DisclosureSEC source: 0001209191-22-037399 · doc4.xml · derivative · entry 2 LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 6,000 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:05 UTC |
LARANJEIRA CHARLES ANTHONYChief Technical Officer
|
Exercise / conversionCommon Stock | 6,000 | $38.35 | $230,100.00 |
DisclosureSEC source: 0001209191-22-037399 · doc4.xml · nonDerivative · entry 1 LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 23:45 UTC |
SLONIN JONATHANChief Clinical Officer
|
SaleStock Option (Right to Buy) · Derivative | 24,800 | $0.00 Strike: $59.39 | $0.00 |
DisclosureSEC source: 0001209191-22-035232 · doc4.xml · derivative · entry 3 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,800 Underlying: Common Stock · 24,800 shares Expires 2032-06-08 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 23:45 UTC |
SLONIN JONATHANChief Clinical Officer
|
GrantCommon Stock | 9,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035232 · doc4.xml · nonDerivative · entry 2 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,097 F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 19:22 UTC |
Froimson MarkDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,225 | $0.00 Strike: $59.39 | $0.00 |
DisclosureSEC source: 0001209191-22-035218 · doc4.xml · derivative · entry 2 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,225 Underlying: Common Stock · 8,225 shares Expires 2032-06-08 Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 19:22 UTC |
Froimson MarkDirector
|
GrantCommon Stock | 1,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035218 · doc4.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,068 F1 · shares: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 19:41 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 19,900 | $0.00 Strike: $59.39 | $0.00 |
DisclosureSEC source: 0001209191-22-035230 · doc4.xml · derivative · entry 3 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,900 Underlying: Common Stock · 19,900 shares Expires 2032-06-08 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.